Recombinant Human FGF2 Enzyme Inhibitors

Recombinant Human FGF2 Enzyme InhibitorsDescription Basic Fibroblast Growth Factor is found in almost all tissues of mesodermal and neuroectodermal origin and also in tumors derived from these tissues. Endothelial cells produce large amounts of this factor. Some bFGF is associated with the extracellular matrix of the subendothelial cells. Many cells express bFGF only transiently and store it in a biologically inactive form. The mechanism by which the factor is released by the cells is not

Y02001N Purity ≥95%

and sample handling

Closure: SnapLock flip cap ensures leak-proof seal

RNA is indirectly protected because RNases are inactivated

Shipping and Storage at Ambient Temperatur

considerably lowers noise level

Swissprot No P20700 Gene Accession BC012295 WB Predicted band size 67 kDa WB Positive control WB Recommended dilution 1000-5000 IHC predicted cell location Predicted cell location: Nucleus IHC positive control Positive control: Human tonsil IHC Recommed dilution Recommended dilution: 50-200 Storage

allowing the incubator door to close fully without affecting sealing

forming the small latent TGF-β1 complex (8–10)

increases gel stability and minimizes protein modification

Immunohistochemical analysis of paraffin-embedded Human liver cancer tissue or FARS2 antigen-treated (Neutralization experiment) using P113414(FARS2 Antibody) at dilution 1/160

This product was previously listed under catalog number 15-2250 and is now updated to BF-44014062 for improved product management